Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
10/2007
10/25/2007US20070249616 Substituted 1-Benzyl-4-Substituted Piperazine Analogues
10/25/2007US20070249591 Biaryl Amino Acids and Their Use in Dna Binding Oligomers
10/25/2007CA2648555A1 Diaryl substituted alkanes
10/25/2007CA2648543A1 Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
10/25/2007CA2648202A1 Compositions useful as inhibitors of voltage-gated sodium channels
10/25/2007CA2645961A1 Aminomethyl pyridine derivatives, method for preparing same and therapeutic use thereof
10/24/2007EP1847540A1 Nouveaux dérivés d'épothilone, leur procédé de production et leur utilisation pharmaceutique
10/24/2007EP1847527A1 Novel benzamidine compound
10/24/2007EP1847263A2 Inhibitors against the production and release of inflammatory cytokines
10/24/2007EP1846373A2 Derivatives of 4-demethylpenclomedine, use thereof and preparation thereof
10/24/2007EP1846372A2 Compounds for inflammation and immune-related uses
10/24/2007EP1846365A1 Diamine calcium channel blockers
10/24/2007EP1846363A2 Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
10/24/2007EP1846362A2 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
10/24/2007EP1845779A1 Anti-bacterial compounds
10/24/2007EP1534671A4 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/24/2007CN101061106A Potentiators of glutamate receptors
10/24/2007CN101061105A Potentiators of glutamate receptors
10/24/2007CN101061101A Aroylfuranes and aroylthiophenes suitable
10/24/2007CN101061098A Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors
10/24/2007CN101058564A Aryl alkyl carbamate derivatives production and use thereof in therapy
10/24/2007CN101058559A Method of continuously synthesizing ionic liquid at room temperature
10/24/2007CN100344647C Marking method and selective adsorption method for phosphorylating peptide, coordination compound used for the same method and producing method for the same coordination compound
10/24/2007CN100344632C 稠合的呋喃化合物 Fused furan compound
10/24/2007CN100344616C Compounds for the treatment of metabolic disorders
10/23/2007US7285680 β-alanine derivatives and the use thereof
10/23/2007US7285676 Synthesis of chiral 2-alkyl amino acids
10/23/2007US7285670 4,5-Dihydro-2-(2,4-dihydroxyphenyl)-4-methyl-thiazole-4(S)-carboxylic acid by coupling a mono- or polyalkoxybenzonitrile with a cysteine ester and alkylating the thiazoline ring at the 4-carbon position; preferably a phase transfer agent such as N-9-anthracenylmethylcinchonidinium chloride is used
10/23/2007US7285568 Substituted p-(2-alkoxy-2-acylethyl)biphenyl compounds, e.g., 1-[4'-(2-ethoxy-3-morpholin-4-yl-3-oxopropyl)biphenyl-3-yl]-3-heptyl-1-methylurea; useful in human or veterinary medicine: dermatology, cardiovascular diseases, immune diseases, and diseases associated with lipid metabolism
10/23/2007US7285565 E.g., 3-(2-(4-[(2-aminosulfonyl)phenyl]benzoylamino)phenoxy)benzamidine; 7-(2-(4-[(2-aminosulfonyl)phenyl]benzoylamino)-4-trifluoromethylphenoxy)1-aminoisoquinoline; and 3-hydroxycarbonyl-2-(4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenoxynaphthalene; highly selective
10/18/2007WO2007118137A1 Benzamide derivatives as inhibitors of histone deacetylase
10/18/2007WO2007118041A1 Compounds which modulate the cb2 receptor
10/18/2007WO2007117981A2 Selective hydroxamate based mmp inhibitors
10/18/2007WO2007117165A1 New pharmaceutical compounds
10/18/2007WO2007117027A1 Process for the production of organic oxides
10/18/2007WO2007116374A1 Novel sulfonamide compounds
10/18/2007WO2007116314A1 N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites
10/18/2007WO2007115935A1 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ACTIVE COMPOUNDS
10/18/2007WO2007115643A1 Substituted enaminocarbonyl compounds
10/18/2007WO2007076473A3 Substituted pyrimidinyloxy ureas useful as inhibitors of protein kinases
10/18/2007US20070244197 Bactericide against gramnegative bacteria; respiratory system disorders
10/18/2007US20070244172 Compounds for the treatment of metabolic disorders
10/18/2007US20070244171 Compounds for the treatment of metabolic disorders
10/18/2007US20070244156 Sulfonylamino-acetic acid derivatives
10/18/2007US20070244141 Compounds for the treatment of metabolic disorders
10/18/2007US20070244117 Novel Hydroxamic Acid Esters and Pharmaceutical Use Thereof
10/18/2007US20070243612 Novel Compounds for Modulating Cell Proliferation
10/18/2007DE102007014117A1 Flüssigkristalline Mischungen und Flüssigkristallanzeigen Liquid-crystalline mixtures and liquid crystal displays
10/18/2007CA2648978A1 N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites
10/18/2007CA2648914A1 Pyridyloxadiazole substituted compounds and compositions
10/18/2007CA2648804A1 Benzamide derivatives as inhibitors of histone deacetylase
10/18/2007CA2648074A1 11.beta.-hydroxysteroid dehydrogenase type 1 active compounds
10/18/2007CA2646917A1 Novel sulfonamide compounds
10/18/2007CA2644783A1 Selective hydroxamate based mmp inhibitors
10/18/2007CA2643863A1 Compounds which modulate the cb2 receptor
10/17/2007EP1845087A1 Hydroxyphenyl derivatives and biological applications thereof
10/17/2007EP1845086A1 N-(2-substituted phenyl)-n-methoxycarbamates and their preparation as well as use
10/17/2007EP1844780A2 Derivatives of aryl-quinazoline/aryl-2-amino-phenyl methanone which promote the release of parathyroid hormone
10/17/2007EP1844778A1 Agent for prevention/therapy of disease caused by keratinocyte growth
10/17/2007EP1844766A2 Inhibitors against the production and release of inflammatory cytokines
10/17/2007EP1844014A1 Process for producing heteroaromatic carboxylic acids
10/17/2007EP1844003A1 Novel biaromatic compounds, inhibitors of the p2x7-receptor
10/17/2007EP1844001A1 Metabolites of 2-arylpropionic acid derivatives and pharmaceutical compositions containing them
10/17/2007EP1474395B1 Nicotinamide derivates useful as p38 inhibitors
10/17/2007EP1366122B1 Azo dyes, a process for their preparation and their use in the production of coloured plastics or polymeric colour particles, and in the dyeing or printing of hydrophobic fibre materials
10/17/2007EP1341769B1 Bacterial gyrase inhibitors and uses thereof
10/17/2007CN101056858A (hetero)cyclyl(thio) carboxylic acid anilides for controlling pathogenic fungi
10/17/2007CN101056857A Process for preparation of isonicotinic acid derivatives
10/17/2007CN101056856A Method for preparing torsemide crystal with pure state
10/17/2007CN101054395A Platinum metal pyridine complexes with light sensitive and solvent color transition effect
10/17/2007CN101054362A Method of synthesizing ion liquid at room temperature
10/17/2007CN101054330A Synthesis method for biphenyl compound
10/17/2007CN100343668C Novel fluorescent label compounds
10/17/2007CN100343339C Pyridone dyes, a process for their preparation and thier use in the production of coloured plastics or polymeric colour particles
10/17/2007CN100343338C Yellow anionic disazo dyes
10/17/2007CN100343233C Malononitrile compounds and their uses
10/16/2007US7282608 Inhibitors of histone deacetylase
10/16/2007US7282590 Drug conjugates
10/16/2007US7282587 Process for the preparation of 10,11-dihydro-5h-dibenzo[a,d]cyclohept-5-enes and derivatives thereof
10/16/2007US7282512 Such as 1-benzylcyclobutyl (1S)-1-(oxo{[(1R)-1-phenylethyl]amino}acetyl)pentylcarbamate for treatment of osteoporosis
10/16/2007US7282502 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis; N-(2-Benzoyl-4-chloro-phenyl)-4-chloro-benzenesulfonamide; N-[4-Chloro-2-(pyridin-2-ylsulfanyl)-phenyl]-4-isopropyl-benzenesulfonamide
10/16/2007US7282501 Drugs for treatment of Syndrome X, diabetes, hypoglycemic agents, antilipemic agents, arteriosclerosis and cardiovascular agents
10/16/2007US7282494 Heteroaryl diazacycloalkanes, their preparation and use
10/11/2007WO2007115269A2 Orally bioavailable caffeic acid related anticancer drugs
10/11/2007WO2007114855A2 Glucagon receptor antagonists, preparation and therapeutic uses
10/11/2007WO2007114213A1 Substituted bicyclic cyclic derivative and use thereof
10/11/2007WO2007113327A2 Fungicide n-cyclopropyl-sulfonylamide derivatives
10/11/2007WO2007113249A2 N-hydroxy-3-(4-{3-phenyl-s-oxo-propenyl}-phenyl)-acrylamide derivatives and related compounds as histone deacetylase inhibitors for the treatment of cancer
10/11/2007WO2007113235A1 Process for preparing 6,7-dihydro-5h-imidazo[1,5-a]pyridin-8-one
10/11/2007WO2007113202A1 Piperazine derivatives as growth hormone secretagogue (ghs) receptor agonists
10/11/2007WO2007112842A1 Active ingredient combinations with insecticidal properties
10/11/2007WO2007112505A1 Glyceride ester derivatives of herbicidal compounds and compositions thereof
10/11/2007WO2007096072A3 New pyridin-3-amine derivatives
10/11/2007WO2007093533A3 Dehydrogenation process
10/11/2007WO2007069777A3 Fungicidal composition containing carboxylic acid amide derivative
10/11/2007WO2000072801A3 Alpha v integrin receptor antagonists
10/11/2007US20070238763 Urea derivatives as integrin a4 antagonists
10/11/2007US20070238759 Novel Polymorph V of Torasemide
10/11/2007US20070238735 Cyclooxygenase-2 selective inhibitors, compositions and methods of use
10/11/2007US20070238722 N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones
1 ... 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 ... 633